About Rx AOD9604 — AOD9604 Research Spec Sheet
About Rx AOD9604
Rx AOD9604 is an independent editorial project that publishes summaries of the peer-reviewed research literature on AOD9604, and contextual coverage of related compounds in the HGH-fragment and metabolic-peptide research record. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.
The AOD9604 literature spans six randomized double-blind placebo-controlled human trials, approximately 900 subjects, and a preclinical record extending from 2000 through the present. It is a documented, numbered, and citable body of work. This site's job is to make that record readable — mechanism to clinical outcome to regulatory status — without editorializing about its value beyond what the data shows.
The 'Rx' prefix in the domain name is a model designation, not a prescription claim. It positions this site in the reference-grade register — the spec sheet, not the showroom. This site does not prescribe, dispense, compound, or consult on AOD9604 or any compound. The standing STATUS chip in the navigation reflects the regulatory facts: RUO — Not FDA Approved.
The domain modifier 'Rx' is editorial framing — a reference to the spec-sheet, clinical-record register this site occupies relative to the literature, not a claim that this site offers treatment, consultation, or prescription services. We are explicit about that distinction here and across the site.
We have no commercial relationship with any research chemical supplier, compounding pharmacy, or manufacturer. No affiliate links appear on this site. No products are promoted. The research record is what it is — six human trials, one discontinued program, an unresolved preclinical-to-human translation gap, and a growing secondary research direction in cartilage biology — and this site reads it plainly.
Sources: all primary citations are from PubMed, DOI-indexed journals, the WADA Prohibited List, and the FDA advisory committee record. The full reference list is on the published references and citations page.